Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.53 |
| ▸ | EGFR | P00533 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | GMNN | O75496 | 4/20 | 0.49 |
| ▸ | TP53 | P04637 | 4/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.49 |
| ▸ | BLM | P54132 | 4/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5688463 | 1.00 | MAOB (0.53) | MAOBEGFRKDM4EMEN1GMNN | |
| SCHEMBL5157754 | 0.82 | KMT2A (0.52) | MEN1CYP1A2CYP3A4MAPTMAPK1 | |
| SCHEMBL5159821 | 0.81 | MAOB (0.58) | MAOBEGFRKDM4EMEN1GMNN | |
| SCHEMBL5159630 | 0.80 | MAOB (0.53) | MAOBEGFRKDM4EMEN1TP53 | |
| SCHEMBL5159642 | 0.80 | MAOB (0.53) | MAOBEGFRKDM4EMEN1TP53 | |
| SCHEMBL5688083 | 0.78 | MAOB (0.60) | MAOBEGFRKDM4EMEN1GMNN | |
| SCHEMBL5688467 | 0.76 | MAOB (0.61) | MAOBEGFRKDM4EMEN1GMNN | |
| SCHEMBL7140529 | 0.76 | MAOB (0.51) | MAOBEGFRKDM4EMEN1TP53 | |
| SCHEMBL5160059 | 0.76 | MAOB (0.51) | MAOBEGFRKDM4EMEN1TP53 | |
| SCHEMBL5159432 | 0.74 | MAOB (0.49) | MAOBEGFRKDM4EMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050033090-A1 | Process for the preparation of cinnamaldehyde compounds | LYMPHOSIGN INC. (CA) | 2005-02-10 | — | — | US | claimed |
| EP-1638912-A2 | PROCESS FOR THE PREPARATION OF CINNAMALDEHYDE COMPOUNDS | Lymphosign Inc. (CA) | 2006-03-29 | — | — | EP | disclosed |
| US-20050033090-A1 | Process for the preparation of cinnamaldehyde compounds | LYMPHOSIGN INC. (CA) | 2005-02-10 | — | — | US | disclosed |
| WO-2005000777-A2 | PROCESS FOR THE PREPARATION OF CINNAMALDEHYDE COMPOUNDS | LYMPHOSIGN INC. (CA) | 2005-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050033090-A1 | Process for the preparation of cinnamaldehyde compounds | CES2, MCCC2, BCKDK | MAOB 808/4885EGFR 3840/4885KDM4E 2342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.